SHARON, Pa., Jan. 4 /PRNewswire/ -- NanoLogix, Inc. today announced that the Company’s board has been expanded to include David F. Rivers, who will bring expertise and guidance as the Company continues on the path toward commercialization of its medical diagnostic products and near term commercial demonstration of its hydrogen generation system technologies.
David F. Rivers was with Pfizer for 34 years. He was Vice President, in charge of the Research, Development, and Engineering operations for the Schick & Wilkinson Sword Group since 1993. In this position, he was responsible for all new product and process activity for the business worldwide. Mr. Rivers worked in the Fisher Body Division of General Motors’ in Engineering, Quality, and Manufacturing operations before joining Pfizer. He began his career at Pfizer in 1969 as a Production Superintendent, in the Schick Operations and held increasingly responsible positions in the Schick and Consumer Products groups in both Manufacturing, Engineering and Research and Development. He retired from Pfizer in October 2003 to become CEO of the Patriot Lift Company. Patriot Lift Company (www.patriotlift.com) manufactures and sells the exclusive technology for Pneumatic automation of landing gear and stabilizers for the Trucking Industry.
Mr. Rivers graduated from Northeastern University and holds degrees in Mechanical Engineering. He has many advanced studies in Engineering, Materials Management, Management Leadership, and Six Sigma Quality. Mr. Rivers has been on the Advisory Board of Quinnipiac University in Hamden, CT for the past 25 years. He has been a key supporter, contributor and is on the board of the One Church One Family activities for the USVI.
David C. McClelland, President of NanoLogix, commented, “David Rivers brings a depth of knowledge, and an incomparable contact list that will contribute immediately to commercialization of products, intellectual property protection and capitalization. On behalf of NanoLogix’s Board, we welcome David aboard.”
About NanoLogix, Inc.
NanoLogix is a nanobiotechnology company that engages in the research, development, and commercialization of technologies for the production of bacteria, disease testing kits, alternative sources of fuel, cancer therapy, and remediation of toxic materials. The Company’s patents span the identification and antibiotic sensitivity testing of 34 disease-producing bacteria, including M. tuberculosis (TB), Mycobacterium avium-intracellulare (MAI), pseudomonas, and nocardia. These bacteria are cited as prominent causes of morbidity and mortality in patients with cancer, cystic fibrosis, and AIDS. Additionally, NanoLogix owns a patent for the nontoxic induction of apoptosis (a method for inducing a genetically based induction of “cell suicide”) in cancer cells utilizing hydrophobic hydrocarbons. NanoLogix is currently implementing a technology application for biogas products and services designed to assist in worldwide energy independence and reduce pollution from renewable, environmentally-friendly energy sources.
Forward-Looking Statements
This press release contains statements, which may constitute “forward- looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Phoenix Associates Land Syndicate, and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
FOR FURTHER INFORMATION, go to the Company’s website at: http://www.NanoLogix.net, or contact:
Brass Bulls Corp., (866) 342.2700
NanoLogix, Inc.
CONTACT: Brass Bulls Corp., +1-866-342-2700
Web site: http://www.NanoLogix.net//
